至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver

Biochim Biophys Acta Mol Basis Dis. 2020; 
Canivet CM, Bonnafous S, Rousseau D, Leclere PS, Lacas-Gervais S, Patouraux S, Sans A, Luci C, Bailly-Maitre B, Iannelli A, Tran A, Anty R, Gual P.
Products/Services Used Details Operation
Plasmid DNA Preparation … 245 Overexpression of FNDC5 HepG2 cells (ATCC HB-8065) were transfected with pcDNA-FNDC5 and the empty plasmid (mouse FNDC5, #Omu04150D, GenScript) using a Jet PEI-hepatocyte mix assay (102-05NOzyme) … Get A Quote

摘要

The proteolytic cleavage of Fibronectin type III domain-containing 5 (FNDC5) generates soluble irisin. Initially described as being mainly produced in muscle during physical exercise, irisin mediates adipose tissue thermogenesis and also regulates carbohydrate and lipid metabolism. The aim of this study was to evaluate the hepatic expression of FNDC5 and its role in hepatocytes in Non-Alcoholic Fatty Liver (NAFL). Here we report that hepatic expression of FNDC5 increased with hepatic steatosis and liver injury without impacting the systemic level of irisin in mouse models of NAFLD (HFD and MCDD) and in obese patients. The increased Fndc5 expression in fatty liver resulted from its upregulation in hepatocytes an... More

关键词

FNDC5; Irisin; Liver injury; NAFLD; Steatosis